CVE-2026-53829 — HIGH (8.0)

Q: How severe is CVE-2026-53829?

CVE-2026-53829 has been rated HIGH with a CVSS base score of 8.0/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2026-53829?

Check the references section above for vendor advisories and patch information. Affected products include: Openclaw Openclaw.

Vulnerability Description

OpenClaw before 2026.5.18 contains an approval display truncation vulnerability allowing authenticated users to hide command suffixes from approvers. Attackers can submit oversized exec commands with benign prefixes and malicious suffixes to execute unauthorized operations after approval.

CVSS Score

8.0

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

UNCHANGED

Confidentiality

HIGH

Integrity

HIGH

Availability

HIGH

Affected Products

Vendor	Product	Versions
Openclaw	Openclaw	< 2026.5.18

Related Weaknesses (CWE)

CWE-451

References

https://github.com/openclaw/openclaw/security/advisories/GHSA-xww8-gqvh-92x9MitigationVendor Advisory
https://www.vulncheck.com/advisories/openclaw-command-truncation-in-exec-approvaThird Party Advisory

FAQ

What is CVE-2026-53829?

CVE-2026-53829 is a vulnerability with a CVSS score of 8.0 (HIGH). OpenClaw before 2026.5.18 contains an approval display truncation vulnerability allowing authenticated users to hide command suffixes from approvers. Attackers can submit oversized exec commands with ...

How severe is CVE-2026-53829?

CVE-2026-53829 has been rated HIGH with a CVSS base score of 8.0/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2026-53829?

Check the references section above for vendor advisories and patch information. Affected products include: Openclaw Openclaw.